Abstract
This study evaluated the effectiveness of vitamins A, C, and E, with selenium, in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL). This was a prospective, controlled study performed at a tertiary teaching and research hospital. Over a 32-month period, patients were treated with either our standard ISSNHL treatment regimen plus vitamins A, C, and E and selenium (ACE+ group) or with only our standard ISSNHL treatment regimen (ACE− group). The demographics, additional symptoms, mean initial and final hearing levels, mean hearing gain, and recovery data were compared between the two groups. The ACE+ group, consisting of 70 (55.5 %) patients, received vitamin A (natural beta-carotene, 26,000 IU), vitamin C (ascorbic acid, 200 mg), vitamin E (d-alpha-tocopherol, 200 IU), and selenium (50 μg) twice daily for 30 days in addition to our ISSNHL treatment regimen: methylprednisolone at an initial dose of 1 mg/kg body weight per day, tapered over 14 days; Rheomacrodex® [(10 g of dextran and 0.9 g of NaCl)/100 ml] 500 ml daily for 5 days; Vastarel® 20-mg tablet (20 mg of trimetazidine dihydrochloride) three times daily for 30 days; and ten 60-min hyperbaric oxygen (HBO) sessions (2.5 absolute atmospheres of 100 % O2), once daily, starting the day of hospitalization. The ACE− group comprised 56 (44.4 %) patients, who received only our ISSNHL treatment regimen. The mean hearing gains were 36.2 ± 20.3 dB in the ACE+ group and 27.1 ± 20.6 dB in the ACE− group. The mean hearing gain rates were significantly higher in the ACE+ group than in the ACE− group (p = 0.014). Treatment with vitamins A, C, and E and selenium was effective in ISSNHL patients undergoing treatment with methylprednisolone, dextran, trimetazidine dihydrochloride, and HBO, and might be more effective when the initial hearing level is below 46 dB.
This is a preview of subscription content,
to check access.

References
Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolaryngol Clin North Am 29(3):393–405
Fetterman BL, Saunders JE, Luxford WM (1996) Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17(4):529–536
Whitaker S (1980) Idiopathic sudden hearing loss. Am J Otol 1(3):180–183
Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84
Rybak LP, Whitworth C, Somani S (1999) Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 109:1740–1744
Masaya T, Matti A (2004) Functional significance of nitric oxide in the inner ear. In Vivo 18:345–350
Joachims HZ, Segal J, Golz A et al (2003) Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 24(4):572–575
Kanzaki J, Inoue Y, Ogawa K, Fukuda S et al (2003) Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 30:123–127
Schuknecht HF, Donovan ED (1986) The pathology of idiopathic sudden sensorineural hearing loss. Arch Otorhinolaryngol 243(1):1–15
Kopke R, Allen KA, Henderson D et al (1999) A radical demise toxins and trauma share common pathways in hair cell death. Ann N Y Acad Sci 884:171–191
Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR (2011) Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol 17(3):201–211
Ohlemiller KK, Dugan LL (1999) Elevation of reactive oxygen species following ıschemia-reperfusion in mouse cochlea observed in vivo. Audiol Neurootol 4:219–228
Clerici WJ, DiMartino DL, Prasad MR (1995) Direct effects of reactive oxygen species on cochlear outer hair cell shape invitro. Hear Res 84:30–40
Clerici WJ, Yang L (1996) Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 101:14–22
Capaccio P, Pignataro L, Gaini LM et al (2012) Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 269(2):449–453
Haberkamp TJ, Tanyeri HM (1999) Management of idiopathic sudden sensorineural hearing loss. Am J Otol 20(5):587–592
Shemirani NL, Schmidt M, Friedland DR (2009) Sudden sensorineural hearing loss: an evaluation of treatment and management approaches by referring physicians. Otolaryngol Head Neck Surg 140(1):86–91
Inna M, Barbara C (2011) Protecting the auditory system with glucocorticoids. Hear Res 281:47–55
Wei BP, Stathopoulos D, O’Leary S (2013) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 7:CD003998. doi:10.1002/14651858.CD003998.pub3
Alex B, Raoul B, Roberto C (2008) Combination therapy (ıntratympanic dexamethasone + high-dose prednisone taper) for the treatment of ıdiopathic sudden sensorineural hearing loss. Otol Neurotol 29:453–460
Daisuke A, Hideki T, Shigeru K (2006) Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 134:783–787
Himeno C, Komeda M, Izumikawa M et al (2002) Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 167(1–2):61–70
Grundy JE (1998) Current antiviral therapy fails to prevent the pro-ınflammatory effects of cytomegalovirus ınfection, whilst rendering ınfected cells relatively resistant to ımmune attack. In: Ed Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) CMV-related ımmunopathology. Monogr. Virol Basel, Karger, vol 21, pp 67–89
Westerlaken BO, Stokroos RJ, Dhooge IJ et al (2003) Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol 112(11):993–1000
Suzuki H, Hashida K, Nguyen KH et al (2012) Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 122:1154–1157
Bennett MH, Kertesz T, Perleth M et al (2012) Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 10:CD004739. doi:10.1002/14651858.CD004739.pub4
Narkowicz CK, Vial JH, McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 19(2):71–80
Tabuchi K, Tsuji S, Fujihira K et al (2002) Outer hair cells functionally and structurally deteriorate during reperfusion. Hear Res 173(1–2):153–163
Clarkson PM, Thompson HS (2000) Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr 72(2 Suppl):637–646
Krinsky NI (1989) Antioxidant functions of carotenoids. Free Radic Biol Med 7:617–635
Joong HA, Hun HK, Young-Jin K, Jong WC (2005) Anti-apoptotic role of retinoic acid in the inner ear of noise-exposed mice. Biochem Biophys Res Commun 335:485–490
Ulf-Rüdiger H, Ilka F, Jürgen B et al (2008) Ascorbic acid reduces noise-ınduced nitric oxide production in the guinea pig ear. Laryngoscope 118(5):837–842
Kong WJ, Han YC, Wang Y et al (2004) Protective roles of vitamin E and coenzyme Q10 in the inner ear mitochondrial DNA 4834 bp deletion mutation of rats. Zhonghua Er Bi Yan Hou Ke Za Zhi. 39(12):707–711
Padayatty SJ, Katz A, Wang Y et al (2003) Vitamin an antioxidant: evaluation of ıts role in disease prevention. J Am Coll Nutr 22(1):18–35
Gebicki JM, Jurgens G, Esterbauer H (1991) Oxidative stress. In: Sies H (ed) Oxidants and antioxidants. Academic Press, London, pp 371–397
Packer L (1992) Interactions and disease: among antioxidants in health vitamin E and its redox cycle. Proc Soc Exp Biol Med 200(2):271–276
Seidman MD (2000) Effects of dietary restriction and antioxidants on presbyacusis. Laryngoscope 110(5 Pt 1):727–738
Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalianorgans. Physiol Rev 59(3):527–605
Heinrich UR, Brieger J, Stauber RH, Mann WJ (2011) Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss. HNO 59(11):1103–1110
Henry Z, Joachims JS, Avishay G et al (2003) Antioxidants in treatment of ıdiopathic sudden hearing loss. Otol Neurotol 24:572–575
Salganik RI (2001) The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20(5 Suppl):464–472 (discussion 473–475)
Miyako H, Naoki U, Yozo O et al (2008) Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol 128:116–121
Chao-Hui Y, Ming-Tse K, Jyh-Ping P, Chung-Feng H (2011) Zinc in the treatment of ıdiopathic sudden sensorineural hearing loss. Laryngoscope 121:617–621
Office of Dietary Supplements (2013) National Institutes of Health. Vitamin and mineral supplement fact sheets. http://ods.od.nih.gov/factsheets/listVitaminsMinerals. Accessed 26 Sept 2013
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaya, H., Koç, A.K., Sayın, İ. et al. Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 272, 1119–1125 (2015). https://doi.org/10.1007/s00405-014-2922-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-2922-9